Nektar Therapeutics (NKTR) Insider Trading & Ownership $24.94 -1.73 (-6.49%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$24.62 -0.33 (-1.30%) As of 07/18/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Nektar Therapeutics (NASDAQ:NKTR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.25%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$241.48K Get NKTR Insider Trade Alerts Want to know when executives and insiders are buying or selling Nektar Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NKTR Insider Buying and Selling by Quarter Nektar Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/19/2025Howard W RobinCEOSell1,547$10.05$15,547.35 5/19/2025Jonathan ZalevskyInsiderSell714$10.05$7,175.70 5/19/2025Mark Andrew WilsonInsiderSell666$10.05$6,693.30 2/19/2025Howard W RobinCEOSell1,584$15.15$23,997.60 2/19/2025Jonathan ZalevskyInsiderSell686$15.15$10,392.90 12/23/2024Mark Andrew WilsonInsiderSell2,226$13.50$30,051.00 12/19/2024Jonathan ZalevskyInsiderSell3,407$14.10$48,038.70 12/17/2024Howard W RobinCEOSell3,133$15.15$47,464.95 11/19/2024Howard W RobinCEOSell1,085$15.15$16,437.75 11/19/2024Jonathan ZalevskyInsiderSell519$15.15$7,862.85 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/19/2024Howard W RobinCEOSell992$19.20$19,046.40 8/19/2024Jonathan ZalevskyInsiderSell457$19.20$8,774.40 (Data available from 1/1/2013 forward) NKTR Insider Trading Activity - Frequently Asked Questions Who is on Nektar Therapeutics' Insider Roster? The list of insiders at Nektar Therapeutics includes Deep Track Capital, Lp, Howard W Robin, Jillian B Thomsen, Jonathan Zalevsky, Karin Eastham, Mark Andrew Wilson, Myriam Curet, Robert Chess, and Roy A Whitfield. Learn more on insiders at NKTR. What percentage of Nektar Therapeutics stock is owned by insiders? 5.25% of Nektar Therapeutics stock is owned by insiders. Learn more on NKTR's insider holdings. Which Nektar Therapeutics insiders have been selling company stock? The following insiders have sold NKTR shares in the last 24 months: Deep Track Capital, Lp ($99,671.10), Howard W Robin ($190,583.40), Jonathan Zalevsky ($113,511.30), Mark Andrew Wilson ($36,744.30), Myriam Curet ($3,001.50), and Robert Chess ($23,400.00). How much insider selling is happening at Nektar Therapeutics? Insiders have sold a total of 29,821 Nektar Therapeutics shares in the last 24 months for a total of $466,911.60 sold. Nektar Therapeutics Key ExecutivesMr. Howard W. Robin (Age 71)CEO, President & Director Compensation: $1.83M2 recent tradesMr. Mark A. Wilson (Age 52)Senior VP, Chief Legal Officer & Secretary Compensation: $749.99kDr. Jonathan Zalevsky Ph.D. (Age 49)Chief Research & Development Officer Compensation: $1.25MMs. Sandra A. Gardiner (Age 58)Interim Chief Financial Officer Vivian WuDirector of Investor Relations & Corporate AffairsMr. Robert BacciSenior Vice President of Human Resources & Facilities OperationsMs. Jennifer RuddockChief Business OfficerDr. Mary Tagliaferri L.Ac. (Age 58)M.D., Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies PCRX Insider Buying OMER Insider Buying ASMB Insider Buying CPIX Insider Buying LLY Insider Buying JNJ Insider Buying ABBV Insider Buying MRK Insider Buying PFE Insider Buying BMY Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealth This page (NASDAQ:NKTR) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredFREE BUY ALERT: These 3 tiny AI stocks could surgeWe're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | SponsoredWill I be blacklisted?Porter Stansberry says a financial force bigger than 9/11 or COVID is already ripping through America — and mo...Porter & Company | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nektar Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share Nektar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NKTR Stock Alerts